|
|
|
Insider
Information: |
Thompson Tommy G |
Relationship: |
Director |
City: |
Saint Louis |
State: |
MO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
2,385,169 |
|
Indirect Shares
|
5,118,253 |
|
|
Direct
Value |
$23,806,633 |
|
|
Indirect Value
|
$16,137,188 |
|
|
Total
Shares |
7,503,422 |
|
|
Total
Value |
$39,943,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
3
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
4
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
-26.9%
|
104.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Centene Corp |
CNC |
Director |
2021-12-31 |
227,334 |
2021-12-31 |
160,896 |
Premium* |
|
CR Bard Inc |
BCR |
Director |
2017-12-29 |
0 |
2005-10-03 |
0 |
Premium* |
|
Pure Bioscience |
PURE |
Director |
2009-07-01 |
589,537 |
2007-05-23 |
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
|
2024-03-11 |
8,480 |
2024-03-08 |
14,000 |
Premium* |
|
Careview Communications Inc |
CRVW |
Director |
2012-12-26 |
1,325,222 |
2013-04-01 |
4,845,424 |
Premium* |
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
103,986 |
2015-09-03 |
83,600 |
Premium* |
|
Therapeuticsmd Inc |
TXMD |
Director |
2022-08-18 |
5,954 |
2022-08-18 |
14,333 |
Premium* |
|
Physicians Realty Trust |
DOC |
Director |
2024-03-01 |
0 |
2024-03-01 |
0 |
Premium* |
|
Vyant Bio Ord Shs |
VYNT |
Director |
2013-10-10 |
2,500 |
2013-10-10 |
0 |
Premium* |
|
Healthpeak Properties |
PEAK |
Director |
2024-04-26 |
122,156 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PURE |
Pure Bioscience |
Director |
|
2008-01-22 |
4 |
S |
$5.28 |
$105,670 |
D/D |
(20,000) |
105,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-01-23 |
4 |
S |
$5.35 |
$26,750 |
D/D |
(5,000) |
105,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-02-01 |
4 |
S |
$5.41 |
$100,076 |
D/D |
(18,500) |
80,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-02-04 |
4 |
S |
$5.49 |
$35,685 |
D/D |
(6,500) |
80,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-03-03 |
4 |
S |
$5.00 |
$12,500 |
D/D |
(2,500) |
238,600 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2008-03-14 |
4 |
S |
$15.30 |
$15,300 |
D/D |
(1,000) |
0 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-03-24 |
4 |
S |
$5.02 |
$25,100 |
D/D |
(5,000) |
216,100 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-03-25 |
4 |
S |
$5.06 |
$88,550 |
D/D |
(17,500) |
216,100 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-04-01 |
4 |
S |
$5.99 |
$149,645 |
D/D |
(25,000) |
191,100 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-07-24 |
4 |
S |
$5.20 |
$52,000 |
D/D |
(10,000) |
358,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-07-25 |
4 |
S |
$5.15 |
$103,000 |
D/D |
(20,000) |
358,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-10-21 |
4 |
S |
$3.12 |
$46,800 |
D/D |
(15,000) |
328,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-10-22 |
4 |
S |
$3.07 |
$46,088 |
D/D |
(15,000) |
328,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-01-07 |
4 |
S |
$3.40 |
$51,060 |
D/D |
(15,000) |
602,800 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-01-08 |
4 |
S |
$3.29 |
$65,700 |
D/D |
(20,000) |
602,800 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-01-09 |
4 |
S |
$3.32 |
$66,476 |
D/D |
(20,000) |
572,837 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-01-12 |
4 |
S |
$3.15 |
$31,348 |
D/D |
(9,963) |
572,837 |
0 |
- |
|
BCR |
CR Bard Inc |
Director |
|
2013-02-19 |
4 |
S |
$100.25 |
$20,050 |
D/D |
(200) |
7,747 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2013-08-01 |
4 |
S |
$76.02 |
$76,020 |
D/D |
(1,000) |
400 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2014-05-06 |
4 |
S |
$107.16 |
$42,864 |
D/D |
(400) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2015-02-27 |
4 |
S |
$152.73 |
$1,152,238 |
D/D |
(7,500) |
0 |
0 |
- |
|
BCR |
CR Bard Inc |
Director |
|
2015-04-28 |
4 |
S |
$170.43 |
$204,515 |
D/D |
(1,200) |
8,319 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2015-05-21 |
4 |
S |
$182.04 |
$273,057 |
D/D |
(1,500) |
0 |
0 |
- |
|
BCR |
CR Bard Inc |
Director |
|
2015-08-14 |
4 |
S |
$199.25 |
$239,103 |
D/D |
(1,200) |
8,319 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2015-09-29 |
4 |
S |
$139.19 |
$695,935 |
D/D |
(5,000) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|